The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1499
ISSUE1499
July 18, 2016
Onzetra Xsail - Sumatriptan Nasal Powder
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Onzetra Xsail - Sumatriptan Nasal Powder
July 18, 2016 (Issue: 1499)
The FDA has approved Onzetra Xsail (Avanir), a nasal
powder formulation of sumatriptan, for acute treatment
of migraine in adults. Nasal spray formulations of
sumatriptan (Imitrex) and zolmitriptan (Zomig) have
been available for many years....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
